AltPep
Carolyn Tallon currently serves as a Senior Scientist at AltPep since March 2023. Previously, Carolyn held multiple roles at The Johns Hopkins University School of Medicine, including Research Associate, Postdoctoral Fellow, and PhD Candidate, with a focus on neurodegenerative disorders and axon regeneration related to BACE1 activity. Carolyn's experience also includes research assistant positions at McGill University, where work involved imaging cancer cells and investigating antibiotic resistance. Carolyn Tallon earned a Doctor of Philosophy in Pathobiology from The Johns Hopkins University School of Medicine and a Bachelor of Science in Physiology from McGill University.
AltPep
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).